B细胞清除以I型干扰素依赖方式损害疫苗接种诱导的CD8+ T细胞反应
研究在利妥昔单抗治疗的类风湿关节炎患者和B细胞缺陷小鼠中观察疫苗接种或感染后CD8+ T细胞扩增,发现B细胞清除会削弱流感疫苗特异性CD8+ T细胞扩增,且该过程依赖B细胞直接I型干扰素受体信号,提示需重新评估B细胞清除患者的疫苗选择以有效诱导保护性CD8+ T细胞反应。
要点
- 利妥昔单抗治疗的RA患者接种Influvac后流感特异性CD8+ T细胞扩增低于健康对照。
- B细胞缺陷JHT小鼠感染流感或MVA后病毒特异性CD8+ T细胞扩增弱于野生型,但痘病毒感染无差异。
- B细胞直接I型干扰素受体信号是诱导趋化因子和增强MHC-I表达以支持T细胞帮助所必需。
核心结论
- B细胞清除导致新发抗体反应缺陷,并影响包括细胞毒性T细胞在内的细胞免疫应答效果。
- B细胞可根据刺激类型调节CD8+ T细胞反应,该调节依赖B细胞直接I型干扰素受体信号。
- 需重新评估B细胞清除患者疫苗选择以有效诱导保护性CD8+ T细胞反应。
研究设计与样本
- 研究在利妥昔单抗治疗的类风湿关节炎患者和B细胞缺陷小鼠中观察疫苗接种或感染后CD8+ T细胞扩增。
主要发现
- 利妥昔单抗治疗的RA患者接种Influvac后流感特异性CD8+ T细胞扩增低于健康对照。
- B细胞缺陷JHT小鼠感染鼠适应流感病毒或改良痘苗病毒安卡拉株后病毒特异性CD8+ T细胞扩增弱于野生型。
- JHT小鼠感染痘病毒后T细胞扩增与野生型相似,提示无内在CD8+ T细胞扩增缺陷。
- B细胞直接I型干扰素受体信号是诱导B细胞趋化因子及通过增强MHC-I表达支持T细胞帮助所必需。
临床怎么用
- 对B细胞清除患者应重新评估疫苗选择以有效诱导保护性CD8+ T细胞反应。
- B细胞清除患者免疫应答依赖保护性T细胞反应,需关注细胞免疫评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The monoclonal anti-CD20 antibody rituximab is frequently applied in the treatment of lymphoma as well as autoimmune diseases and confers efficient depletion of recirculating B cells. Correspondingly, B cell-depleted patients barely mount de novo antibody responses during infections or vaccinations. Therefore, efficient immune responses of B cell-depleted patients largely depend on protective T cell responses. METHODS: CD8+ T cell expansion was studied in rituximab-treated rheumatoid arthritis (RA) patients and B cell-deficient mice on vaccination/infection with different vaccines/pathogens. RESULTS: Rituximab-treated RA patients vaccinated with Influvac showed reduced expansion of influenza-specific CD8+ T cells when compared with healthy controls. Moreover, B cell-deficient JHT mice infected with mouse-adapted Influenza or modified vaccinia virus Ankara showed less vigorous expansion of virus-specific CD8+ T cells than wild type mice. Of note, JHT mice do not have an intrinsic impairment of CD8+ T cell expansion, since infection with vaccinia virus induced similar T cell expansion in JHT and wild type mice. Direct type I interferon receptor signalling of B cells was necessary to induce several chemokines in B cells and to support T cell help by enhancing the expression of MHC-I. CONCLUSIONS: Depending on the stimulus, B cells can modulate CD8+ T cell responses. Thus, B cell depletion causes a deficiency of de novo antibody responses and affects the efficacy of cellular response including cytotoxic T cells. The choice of the appropriate vaccine to vaccinate B cell-depleted patients has to be re-evaluated in order to efficiently induce protective CD8+ T cell responses.
引用
- Graalmann T, Borst K, Manchanda H, et al. B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner. Ann Rheum Dis. 2021. PMID: 34226189. doi:10.1136/annrheumdis-2021-220435
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。